The short answer
Collagen type numbers identify structurally different proteins and can help describe an ingredient’s parent material. They do not tell a swallowed peptide where to go, and five listed types are not automatically more complete or effective than two. Judge an oral product by its source, form, exact material, amount, quality records and matching human evidence. Dayspan’s approved Collagen Essentials specification uses 10 g of hydrolyzed types I and III from bovine hide, the selected animal source, as a focused foundation; types II, V and X are not added just to extend the label. Qualification of the exact peptide material and the final label remain pending before sale.
Answer sources: Ricard-Blum (2011) · the collagen family; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; NIDDK · your digestive system and how it works; Iwai et al. (2005) · identifying food-derived peptides in blood; NCCIH · different questions require different research; Dayspan Collagen Essentials · current ingredient specification; Dayspan ingredient library · collagen material and evidence status
What do collagen type numbers I, II, III, V and X mean?
Collagen is a family of related proteins rather than one molecule with one job. Roman numerals distinguish members of that family. Their chains, organization and locations in the body differ, which is why type I and type II are not two grades of the same material. A larger numeral does not mean a newer or stronger collagen.
The table focuses on five type numbers commonly printed on multi-collagen supplement labels. It describes normal biology from the cited gene and collagen-family references. Those tissue descriptions explain what the names mean in the body; they do not establish what an oral product will do.
Minor collagens can have essential structural roles even when they occur in smaller amounts. Type V, for example, helps regulate fibrils assembled with type I. Biological importance therefore cannot be converted into a shopping rule that says a powder must contain every biologically important collagen.
| Type | What the biological reference describes | What the type name alone does not establish |
|---|---|---|
| I | A major fibril-forming collagen in tissues including skin, bone and tendon | The source, peptide profile, serving amount or a consumer outcome |
| II | A collagen found primarily in cartilage | That any type II product is native, hydrolyzed or proven for the same joint question |
| III | A fibril-forming collagen found in tissues including skin and blood-vessel walls | That it travels intact to those tissues after it is swallowed |
| V | A lower-abundance collagen that assembles with type I and helps regulate fibril diameter | That adding a source containing type V improves a finished oral formula |
| X | A short-chain collagen expressed by hypertrophic cartilage cells during bone formation | That a label mention predicts an adult bone, cartilage or joint result |
Sources: Ricard-Blum (2011) · the collagen family; MedlinePlus Genetics · how type I collagen is assembled; MedlinePlus Genetics · type II collagen; MedlinePlus Genetics · type III collagen; MedlinePlus Genetics · type V collagen and fibril assembly; NCBI Gene · type X collagen
Why do supplement labels feature five types when biology describes many more?
A widely used scientific classification describes 28 collagen types. Those proteins can be grouped by the structures they help form: some assemble into fibrils, some form networks, some associate with existing fibrils, and others have specialized anchoring or membrane-related roles. The five numerals common on retail labels are therefore a small commercial selection, not a complete map of human collagen biology.
Types I, II, III and V belong to the fibril-forming group, although they do not occur in the same proportions or perform identical structural roles. Type X is a short-chain, network-forming collagen associated with hypertrophic cartilage during endochondral bone formation. Types IV, VI, VII, IX, XI, XII and many others are biologically meaningful too, yet they rarely appear in a front-label type count. That alone shows why five cannot mean complete.
The Roman numeral records scientific identity; it does not rank strength, scarcity, modernity or dose. Type X is not ten times stronger than type I, and type V is not a fifth benefit. A supplement label becomes informative only when the type sits beside the source tissue, processing form, amount and exact material specification.
| Family pattern | Examples | Why this matters when reading a supplement |
|---|---|---|
| Fibril-forming collagens | I, II, III, V and XI | Members can assemble into fibrils, but each type still has its own chains, tissue distribution and material question. |
| Network-forming collagens | IV, VIII and X | A network-forming role in tissue does not mean an oral ingredient creates that network after ingestion. |
| Fibril-associated collagens | IX, XII, XIV, XVI, XIX, XX, XXI and XXII | Many important collagens are absent from common multi-collagen marketing lists. |
| Anchoring, beaded-filament and membrane-associated collagens | VI, VII, XIII, XVII and others | Biological importance and commercial inclusion are separate questions. |
A type count is a category description
Use the numerals to identify parent collagen proteins. Use the exact material, amount and human research to judge whether a product fits your question.
Sources: Ricard-Blum (2011) · the collagen family; MedlinePlus Genetics · how type I collagen is assembled; MedlinePlus Genetics · type II collagen; MedlinePlus Genetics · type III collagen; MedlinePlus Genetics · type V collagen and fibril assembly; NCBI Gene · type X collagen
What is type I collagen, and does type I automatically mean skin support?
Type I is the most abundant collagen in the human body. Its mature molecule normally contains two chains made from the COL1A1 gene and one chain made from COL1A2. Many type I molecules assemble into strong fibrils that contribute structure to skin, bone, tendons and other connective tissues. That broad distribution explains why type I is central to collagen biology; it does not make the numeral a map for an oral ingredient.
Commercial type I collagen can begin in more than one animal tissue. Bovine hide, porcine skin and fish skin or scales are common examples, but the source word alone still does not reveal the extraction process, peptide distribution or serving amount. A marine type I hydrolysate and a bovine type I hydrolysate are both collagen-derived peptide mixtures, yet they need not be the same material.
For a skin question, the useful bridge is a human study of an identified oral material, not the observation that type I exists in skin. The study should state the peptide preparation, amount, participants, duration, comparison and measured skin endpoint. If a product uses another material, type I on both labels is not enough to declare the interventions equivalent.
Direct answer
Type I is prominent in skin, but a type I label does not by itself prove that an oral product improves skin. The exact material and matching human evidence carry that question.
Sources: Ricard-Blum (2011) · the collagen family; MedlinePlus Genetics · how type I collagen is assembled; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; NCCIH · understanding a study’s design
What is type II collagen, and why does its physical form matter so much?
Type II collagen is a fibril-forming collagen made from three alpha-1(II) chains encoded by COL2A1. It is a major structural collagen in cartilage and also occurs in the vitreous body of the eye. That tissue distribution explains the strong association between type II and joint questions, but it still describes normal biology rather than the effect of a capsule or powder.
A type II ingredient can arrive in materially different forms. A native or undenatured preparation aims to retain selected conformational features of the parent protein and is commonly used at milligram-scale amounts. A hydrolyzed type II ingredient has been broken into smaller peptides and is usually evaluated as a peptide material. Their shared Roman numeral does not make their structure, amount or evidence interchangeable.
When a label says type II, read the complete ingredient name before comparing doses or studies. Ask whether the material is native, undenatured, denatured or hydrolyzed; how the relevant form was verified; what amount of the exact material is present; and whether the cited trial tested that preparation. This avoids treating all type II products as one category.
Direct answer
Type II is closely associated with cartilage biology. For a supplement decision, the decisive next word is often native, undenatured or hydrolyzed.
Sources: Ricard-Blum (2011) · the collagen family; MedlinePlus Genetics · type II collagen; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; Harris et al. (2022) · analytical comparison of undenatured type II materials
What is type III collagen, and why is it often named beside type I?
Type III collagen is built from three alpha-1(III) chains encoded by COL3A1. Its fibrils occur in skin, blood vessels, the intestinal wall and other tissues that need a supportive framework with flexibility. Type III often occurs alongside type I, which is why source materials such as skin or hide may be described with both numerals.
That partnership in tissue does not create a separate oral dose for each type inside a hydrolysate. If a label declares 10 g of hydrolyzed types I and III collagen, the 10 g ordinarily describes the named collagen ingredient unless the panel separately quantifies each type. It should not be silently divided into assumed type I and type III amounts.
A types I-and-III description can record the manufacturer’s claim about the parent collagen and help define an ingredient record. It does not independently prove species, tissue, peptide identity or a unique skin, vascular or digestive outcome in the finished formula. Those questions need source records, suitable analytical support and evidence that isolates or appropriately tests the material and outcome.
Direct answer
Types I and III commonly occur together in connective tissues and source materials. Their pairing is descriptive; the finished ingredient specification and evidence determine what else can be said.
Sources: Ricard-Blum (2011) · the collagen family; MedlinePlus Genetics · type III collagen; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; FDA · Supplement Facts labeling guide
What is type V collagen, and why can a low-abundance collagen still matter?
Type V is a fibril-forming collagen found in smaller quantities than type I. Molecules containing type V can combine with type I and help regulate how fibrils assemble and how wide they become. Its lower abundance does not make it biologically unimportant; a component can influence structure without making up most of the structure.
The same nuance is needed on a supplement label. The presence of type V in a source such as eggshell membrane can help describe that source’s composition, but it does not state how much type V reaches a serving after processing. It also does not establish a special hair, skin or connective-tissue outcome from consuming it.
A type V ingredient could earn a future formula role if an exact material, dose and relevant human outcome support that use. The focused source review for this guide did not identify a controlled oral human trial isolating type V as the intervention; that bounded search is not proof that no such trial exists. Until there is a product-specific case, adding the numeral mainly increases the category count.
Direct answer
Type V helps organize collagen fibrils in the body. That fact explains its biology; it does not by itself establish a reason to add it to every oral collagen formula.
Sources: Ricard-Blum (2011) · the collagen family; MedlinePlus Genetics · type V collagen and fibril assembly; Han et al. (2023) · eggshell membrane composition and processing; NCCIH · different questions require different research
What is type X collagen—also called type 10—and is it simply bone collagen?
Type X and type 10 are two ways of writing the same collagen numeral. COL10A1 encodes a short-chain collagen associated with hypertrophic cartilage, especially during the growth-plate transition involved in endochondral bone formation. It belongs to a network-forming branch of the collagen family rather than the fibril-forming group that includes types I, II, III and V.
Calling type X “bone collagen” compresses a developmental process into a consumer slogan. Type X is associated with a stage of cartilage maturation connected to bone development; type I is the dominant collagen of mature bone matrix. Neither tissue fact proves that swallowing a material containing the corresponding type changes bone density, joint structure or another clinical endpoint.
Eggshell membrane can contain types I, V and X as part of a much broader composite of collagen and non-collagen proteins. Listing those three types may accurately describe the native source. It does not mean equal quantities, purified type-specific doses or three independently demonstrated benefits in a finished supplement. The focused source review for this guide did not identify a controlled oral human trial isolating type X as the intervention; that does not prove none exists.
Direct answer
Type X is a real collagen involved in hypertrophic cartilage and endochondral bone formation. Its presence on a label is not standalone evidence for an adult bone or joint benefit.
Sources: Ricard-Blum (2011) · the collagen family; NCBI Gene · type X collagen; Han et al. (2023) · eggshell membrane composition and processing; NCCIH · understanding a study’s design
Does a collagen type target the matching tissue after you swallow it?
A type number is not a delivery address. Digestion breaks dietary proteins into smaller peptides and amino acids. The body absorbs and uses those materials through its own metabolic processes; a piece of type I collagen does not move through the digestive tract as an intact skin fiber and install itself in skin.
Researchers have detected small hydroxyproline-containing peptides in blood after people consumed collagen hydrolysates. That finding answers an absorption question. It does not by itself show that a peptide reaches one chosen tissue, changes a visible feature or produces the same result as the original collagen structure in the source tissue.
This distinction protects the meaning of both kinds of research. Tissue biology explains what collagen types do when the body makes and organizes them. An oral intervention study must separately test the exact material, population, comparison, duration and outcome. One kind of evidence cannot silently stand in for the other.
Sources: NIDDK · your digestive system and how it works; Iwai et al. (2005) · identifying food-derived peptides in blood; NCCIH · different questions require different research
Source, collagen type and processing form answer three different questions
Source names the animal and tissue used to make an ingredient. Type identifies collagen family members associated with that source. Form tells you what processing did to the material. A useful label reading therefore keeps all three fields instead of compressing them into a single claim such as five types.
Bovine hide, fish skin, cartilage and eggshell membrane begin with different tissue compositions. A manufacturer may then preserve a native structure, denature the material into gelatin or hydrolyze it into shorter chains. The resulting ingredients are not interchangeable merely because collagen appears in each name.
The examples below are common category patterns, not guarantees about every material from a species. A 2024 laboratory comparison of ten commercial hydrolysates found broadly similar amino-acid profiles but meaningful differences in peptide lengths and abundances. The exact ingredient specification and finished label therefore control the answer for a real product. Source also matters for dietary preferences and allergens, which a type count cannot communicate.
| Field | Question it answers | Example of useful detail |
|---|---|---|
| Source | Where did the material begin? | Animal species and tissue, such as fish skin or chicken cartilage |
| Type | Which collagen family members are associated with the material? | Types I and III, or type II |
| Form | What structure or processing state is supplied? | Native or undenatured, gelatin, hydrolysate or peptides |
| Amount | How much of the named material is in one stated serving? | An individual ingredient amount rather than only a blend total |
Sources: Martínez-Puig et al. (2023) · collagen source, composition and processing forms; Oztug (2024) · peptide profiles across commercial collagen hydrolysates; GELITA · collagen peptide manufacturing and properties; FDA · Supplement Facts labeling guide
How do bovine, porcine, marine, chicken and eggshell sources differ?
Source tells you more than the animal name. The tissue matters because hide, skin, scales, cartilage and eggshell membrane begin with different mixtures. Processing matters because the manufacturer may extract gelatin, produce a broad hydrolysate, preserve selected native structure or isolate a more narrowly specified material. The finished specification should connect all three facts.
The patterns below are common starting points, not guarantees. A fish-derived ingredient is not automatically one uniform “marine collagen,” and a bovine-derived powder does not reveal its peptide profile merely by naming cattle. Species and tissue should be checked against the ingredient record, not inferred from a picture or a Roman-numeral list on the front.
Source also affects practical fit. Fish and egg are major food allergens under U.S. labeling law, so an ingredient containing their protein requires the applicable declaration unless a lawful exemption applies; FDA also requires the fish species to be named. Bovine and porcine sources can matter for religious, cultural or dietary preferences. These are product-selection facts; they are not evidence that one source is universally more effective.
| Common source pattern | What it may help explain | Allergen or dietary question | What still needs verification |
|---|---|---|---|
| Bovine hide | A tissue rich in types I and III that is often processed into gelatin or hydrolyzed peptides | Animal origin affects dietary fit; bovine origin alone does not establish an allergen-free product | Exact tissue, country of origin, processing, peptide specification and complete label |
| Porcine skin | A tissue rich in types I and III that is often processed into gelatin or hydrolyzed peptides | Animal origin can affect religious or dietary preferences; certification needs its own record | Exact material, processing, declared amount and relevant certification where claimed |
| Fish skin or scales | Often a type-I-rich source for gelatin or peptides | Check the fish species and applicable fish-allergen declaration | Exact tissue, complete label, peptide profile and sensory performance |
| Chicken sternum or cartilage | Can supply type-II-rich material in native, undenatured or hydrolyzed form | Animal origin and the complete product's allergen information remain separate questions | The complete form name, retained structure where relevant, amount and matched study |
| Eggshell membrane | A composite matrix that can contain collagens I, V and X plus many non-collagen proteins | Check the applicable egg-allergen declaration for egg-derived protein | Complete label, total material amount, type-specific quantities and exact processing |
Source is a traceability field
Use source to check origin, allergen and dietary fit. Use the exact processed material and human evidence to evaluate an outcome claim.
Sources: Martínez-Puig et al. (2023) · collagen source, composition and processing forms; Han et al. (2023) · eggshell membrane composition and processing; FDA · food allergens and label declarations; Oztug (2024) · peptide profiles across commercial collagen hydrolysates
What does “types I and III collagen peptides” mean after hydrolysis?
In intact tissue, a collagen type names a particular parent protein with defined chains and higher-order structure. During manufacture, heat, extraction and enzymatic hydrolysis can unfold that structure and cut the long chains into many shorter peptides. A hydrolyzed powder is therefore not a jar of miniature, intact type I or type III fibers.
On a collagen-peptide label, the type statement usually records the manufacturer’s claim about the parent collagen. The word hydrolyzed describes the finished ingredient’s processed form. Parent type, species and tissue should be supported by supplier source records and suitable identity methods; peptide and molecular-weight specifications describe the finished hydrolysate. One field cannot prove the others.
Hydrolysis is also not one universal recipe. Enzyme choice, temperature, time and filtration can produce mixtures with different molecular-weight distributions and peptide sequences. In a 2024 laboratory comparison, ten commercial collagen hydrolysates had broadly similar amino-acid profiles while their peptide lengths and measured di- and tripeptide abundances differed. Two products can therefore share a type list and still be analytically different materials.
This does not make the type statement meaningless. It places it in the right layer. Type, source and tissue describe ancestry; molecular-weight distribution, amino-acid composition and peptide profile describe the hydrolysate; the serving amount describes exposure; and a human study describes what happened with one defined intervention.
| Stage | What can be described | Question that remains |
|---|---|---|
| Source tissue | Species, tissue and collagen types normally associated with it | What extraction and processing will retain or change |
| Extracted collagen | Parent proteins and structural form | Whether the material will remain native, become gelatin or be hydrolyzed |
| Hydrolyzed ingredient | A mixture of collagen-derived peptides with a measurable composition | Which exact profile and specification apply to this lot |
| Finished serving | Declared ingredient amount plus every other formula component | Whether the finished product matches the intervention behind a claimed outcome |
The most precise short description
Say “hydrolyzed peptides derived from collagen identified as types I and III,” then name the source and exact material when those specifications are final.
Sources: Ricard-Blum (2011) · the collagen family; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; Oztug (2024) · peptide profiles across commercial collagen hydrolysates; GELITA · collagen peptide manufacturing and properties
Why native type II and hydrolyzed collagen are separate formulation decisions
Native or undenatured type II collagen is intended to preserve structural features of the original protein. Hydrolyzed collagen has been broken into a mixture of shorter chains. The words type II describe identity; native and hydrolyzed describe materially different forms. A comparison that records the type but drops the form loses a decisive part of the ingredient description.
This is also why serving amounts cannot be ranked without context. A milligram quantity of a specified undenatured type II material and a multi-gram serving of hydrolyzed peptides represent different interventions and research questions. The smaller number is not automatically underdosed, and the larger number is not automatically more complete.
Evidence must follow the form actually tested. One industry-connected analytical comparison reported structural and compositional differences among sampled undenatured type II products; a later correction expanded the authors’ commercial disclosures, and a competing manufacturer challenged parts of the method and interpretation. The defensible lesson is to verify the exact material and method instead of assuming category-level interchangeability. Research on one preparation cannot validate a generic hydrolyzed type II ingredient, and evidence for hydrolyzed peptides cannot be reassigned to an undenatured material.
Keep the complete material name
Write native or undenatured type II and hydrolyzed type II as different entries. Do the same for a named peptide preparation and a generic collagen hydrolysate.
Sources: Martínez-Puig et al. (2023) · collagen source, composition and processing forms; Harris et al. (2022) · analytical comparison of undenatured type II materials; Correction (2022) · disclosures and amendments for the undenatured type II comparison; Velasco-Alvarez (2022) · methodological rejoinder to the undenatured type II comparison; NCCIH · understanding a study’s design
How should you read collagen studies without borrowing evidence?
Collagen evidence forms a ladder of different questions. A gene or tissue reference can establish biological identity. A chemistry study can describe a powder. A pharmacokinetic study can measure what appears in blood after ingestion. A randomized trial can test a defined outcome in a defined population. A finished-product study can test the complete formula people actually buy. Moving up that ladder requires new evidence; one rung cannot answer every question above it.
A 2024 randomized, double-blind four-way crossover pilot gave single 10 g doses of four Peptan hydrolysates—fish skin, porcine skin and two bovine-hide materials with different average molecular weights—to six healthy nonsmokers. It measured free and total hydroxyproline, estimated peptide-bound hydroxyproline from their difference and separately measured five selected collagen-related peptides. The study had no placebo and did not test tissue delivery, a clinical benefit, repeated use or long-term safety. Rousselot funded it, supplied the materials and employed five authors. It is useful absorption evidence with a narrow scope.
A 2018 double-blind randomized trial assigned 64 women aged 40 to 60 with photoaged skin to placebo or 1 g per day of one low-molecular-weight collagen hydrolysate derived from sutchi catfish skin for 12 weeks; 53 completed it. The paper reported between-group findings for hydration and selected wrinkle and elasticity measurements. The material contained more than 15% tripeptides, including 3% Gly-Pro-Hyp; the population was narrow, the efficacy analysis used completers, and multiple instrument endpoints matter. Two Newtree employees helped design or conduct the trial, Newtree supplied the material, and another author was affiliated with Jellice, although the paper reported no external funding and declared no conflicts. The result cannot be transferred automatically to every hydrolysate that lists types I and III.
A 2016 randomized trial used 40 mg per day of one chicken-sternum UC-II ingredient for 180 days in 191 adults with knee osteoarthritis and reported WOMAC symptom differences against placebo. The ingredient supplied 1.2 mg of measured undenatured type II collagen, and the primary endpoint was a symptom score. InterHealth sponsored the trial, employed two authors and used the third as a consultant. The trial did not measure structural cartilage regrowth or establish disease modification. It illustrates why a milligram-scale native type II intervention is its own lane; it does not validate hydrolyzed type II, a five-type blend, a skin-focused formula or Dayspan’s unfinished material selection.
| Evidence layer | What it can establish | What it cannot establish alone |
|---|---|---|
| Tissue and gene biology | Where a collagen type occurs and how it participates in normal structure | An effect from swallowing a supplement |
| Ingredient chemistry | Amino-acid composition, peptide distribution, native structure or other measured properties | That the material improves a human outcome |
| Digestion and absorption | Which amino acids or short peptides are detected after ingestion and for how long | A visible, felt or clinical benefit |
| Material-specific human trial | What happened with one material, amount, population, comparison, duration and endpoint | The same result for every source, dose or collagen type |
| Finished-formula trial | What happened with the complete tested combination | A guarantee for another batch, population or personal result |
A practical evidence sentence
Name the material, amount, people, duration and measured outcome before describing a result. Then state whether the product in front of you is actually the same intervention.
Sources: NCCIH · different questions require different research; NCCIH · understanding a study’s design; Oztug (2024) · peptide profiles across commercial collagen hydrolysates; Virgilio et al. (2024) · human absorption across collagen sources and molecular weights; Kim et al. (2018) · randomized trial of one low-molecular-weight collagen hydrolysate; Lugo, Saiyed and Lane (2016) · randomized trial of one undenatured type II material
Which collagen type should you choose for skin, joints, bone, hair or cooking?
A useful answer starts with the goal, then moves to the intervention that was actually studied. It does not start by assigning one body part to each Roman numeral. Type can narrow the material description, but form, dose, population and endpoint determine whether a study answers the question a shopper is asking.
This approach can lead to different formats for different goals. A hydrolyzed peptide powder and a native type II capsule may both be called collagen products while using very different amounts and evidence. Gelatin can be the right answer for a recipe even when it is the wrong physical form for a drink that should not set. A free-glycine formula is another ingredient decision entirely.
The table is a question map rather than a dosing guide. Studied amounts describe particular interventions; they do not establish a universal requirement, an individual recommendation or a Daily Value for collagen.
| Goal or use | Best first question | How the type number helps | Evidence boundary |
|---|---|---|---|
| Skin appearance | Was this exact oral peptide material studied for the named skin measurement? | Types I and III can describe parent material; they do not prove skin delivery | Keep the preparation, amount, population, duration and measured endpoint attached to the result |
| Joint symptoms | Is the product a specified native type II ingredient or a hydrolysate? | Type II is relevant cartilage biology, but form separates distinct intervention categories | A 40 mg native ingredient trial cannot validate an unspecified hydrolyzed blend or show cartilage regrowth |
| Bone questions | Did a human study test this exact material for a bone endpoint in a relevant population? | Types I and X describe different biology; neither numeral establishes a bone outcome | Bone density, turnover markers and fracture risk are different endpoints and cannot be substituted for one another |
| Tendon or training | Was the material tested with the same loading or exercise program? | Type I occurs in tendon, but tissue location is not an intervention | Training, duration, population and the exact peptide material remain part of the studied package |
| Hair or nails | Is there controlled human evidence for the exact product and objective endpoint? | A type I, III or V label does not create hair or nail targeting | Ingredient mixtures, self-ratings and objective counts answer different questions |
| Cooking or texture | Does the recipe need gelling, or a powder that dissolves without setting? | Type count is usually less useful than physical form | Gelatin and hydrolyzed peptides can behave differently even when they share a collagen origin |
| Free glycine | Do you want a declared amount of free glycine or collagen-derived protein? | Collagen type does not quantify free glycine | Collagen-bound amino acids and an added free-form ingredient are separate label amounts |
A better version of “Which type is best?”
Ask: which exact material, in which form and amount, was tested for the outcome I care about—and does this product match it?
Sources: NCCIH · different questions require different research; NCCIH · understanding a study’s design; Kim et al. (2018) · randomized trial of one low-molecular-weight collagen hydrolysate; Lugo, Saiyed and Lane (2016) · randomized trial of one undenatured type II material; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; Gelatine Manufacturers of Europe · gelatin and peptides; NHGRI · what a protein is
Why Dayspan Collagen Essentials currently uses types I and III
Collagen Essentials is a prelaunch combined powder. Its approved specification places 10 g of hydrolyzed bovine-hide collagen peptides, identified as types I and III, beside 200 mg active hyaluronic acid, lutein with zeaxanthin and vitamin C per daily serving. The formula keeps the collagen amount separate from the other active amounts so the complete selection can be read without turning every ingredient into part of a collagen blend.
The ingredient record uses a focused I-and-III foundation because the formula needs a defined collagen material, amount and role. This follows Dayspan’s formulation rule: an added material needs a product job, a declared amount and its own evidence and specification record. Adding separate sources for types II, V and X would not establish added benefit for the finished product. It would add new sourcing, identity, dietary-suitability, flavor, stability and testing questions that each need an answer.
The bovine-hide source, hydrolyzed form and 10 g amount are selected. Qualification of the exact purchased peptide preparation is still pending. Dayspan cannot yet claim a final peptide profile, accepted supplier specification, batch result or absolute absence of every other collagen type. Those require records for the actual material and finished product.
The same restraint applies to outcomes. Research on collagen ingredients does not prove that the complete Essentials blend improves a personal result, and a longer type list would not solve that evidence gap. Final formula records will identify the purchased material and keep its research, specification and testing scope attached to it.
- Keep the approved 10 g collagen foundation clearly declared in the ingredient specification.
- Select the exact peptide material before assigning material-specific research to it.
- Add another collagen form only when it has a defined job, amount and evidence record.
- Publish the qualified material, allergen information, final label and testing scope before sale.
What is approved today?
Bovine-hide types I and III, hydrolyzed form and the 10 g daily amount are approved. The page remains a formula preview: purchased-material qualification, final Supplement Facts, serving weight and batch testing are pending.
Sources: Dayspan Collagen Essentials · current ingredient specification; Dayspan ingredient library · collagen material and evidence status; FDA · Supplement Facts labeling guide; NCCIH · understanding a study’s design
What does a focused I-and-III foundation make easier to verify?
A focused foundation gives the formula a legible center. The approved specification sets 10 g of one hydrolyzed collagen material instead of using a shared blend total that leaves the contribution of several collagen sources unclear. Once that exact purchased material is qualified, the serving, cost, sensory work and evidence bridge will be easier to inspect.
Focus also makes the remaining quality questions concrete. Dayspan will need to qualify the animal and tissue source, processing form, composition limits, traceability records and lot-specific results for the exact material purchased. If multiple collagen materials are ever combined, each one should add a defined job rather than serve as an unmeasured numeral on the front label.
The formula still has other selected ingredients—200 mg active hyaluronic acid, lutein with zeaxanthin and vitamin C—but their roles and amounts remain separate. That structure lets a reader evaluate the complete formula without pretending that every component shares one collagen mechanism or one study. It also makes future revision easier because a new material can be judged against a clear baseline.
| Design decision | What it clarifies now | What must still be finalized |
|---|---|---|
| 10 g hydrolyzed collagen foundation | The approved daily collagen amount is visible apart from the other actives | Final Supplement Facts, serving weight and preparation directions |
| Bovine-hide types I and III as the parent-material description | The selected animal and tissue source is narrower than an all-types claim | Qualification and traceability of the exact purchased peptide material |
| One planned traceable peptide specification | Research and quality records can remain attached to the material once selected | Supplier qualification, specification acceptance and evidence match |
| Other actives declared separately | Each ingredient can keep its own amount, role and evidence boundary | Finished-formula compatibility, stability, sensory work and lawful final copy |
| Versioned formulation record | Readers can distinguish today’s direction from the future sold product | Lot records, final label, launch release and any subsequent change history |
What buyers will be able to verify
The final public record should state what the selected material is, how much the formula contains, why it was chosen and which source, evidence and quality records support it.
Sources: Dayspan Collagen Essentials · current ingredient specification; Dayspan ingredient library · collagen material and evidence status; FDA · Supplement Facts labeling guide; NIH Office of Dietary Supplements · what quality seals mean; Oztug (2024) · peptide profiles across commercial collagen hydrolysates
What would make each collagen type relevant to a future Dayspan product?
Leaving a material out of Essentials does not close the door on future formulas. It sets a clear admission standard: define the consumer question, select the exact material and form, disclose the amount, verify the specification, and show that the human evidence fits the intended message. Each candidate below enters through that same process.
The future decision is material-specific rather than numeral-specific. For example, native type II and hydrolyzed type II would appear as separate candidates because their physical forms, dose scales and evidence differ. An eggshell-membrane ingredient would be evaluated as its whole composite material rather than treated as three purified type-specific ingredients because its source contains I, V and X.
This gives Dayspan room to build products around skin, joints, bone, food use or another defined goal without forcing one powder to carry every possible collagen story. A later formula may use more than one collagen material when the combination itself is coherent and testable.
| Candidate | Possible formulation lane | Evidence needed before a product claim | Why it is not a current Essentials add-on |
|---|---|---|---|
| Hydrolyzed I-and-III material | Focused daily peptide powder | Final material identity, serving, relevant human research, source and quality records | The bovine-hide foundation and 10 g amount are approved; purchased-material qualification remains pending |
| Native or undenatured II | Joint-focused capsule or small-dose format | Verified retained structure, exact active-material amount, matched symptom evidence and complete conflict disclosures | Its milligram-scale native-material evidence belongs to a separate product question |
| Hydrolyzed II | Peptide product evaluated for a defined joint or other outcome | Exact hydrolysate profile, gram-scale amount where applicable and human evidence for that same preparation | It cannot borrow the evidence of native type II merely by sharing the numeral |
| Type-V-containing material | A future material only if its whole composition and job are defined | Measured composition and controlled human evidence for the claimed outcome | Its role in fibril assembly is not an oral outcome study |
| Type-X-containing material | Potentially an eggshell-membrane or other whole-material concept | Exact composite material, amount, relevant adult population and directly measured outcome | Growth-plate biology does not establish an added adult bone or joint benefit |
| Multi-material collagen combination | A formula in which each component has a deliberate role | Evidence matching every claim, plus disclosed amounts and a documented rationale for the complete combination | A longer list alone does not show additive, complementary or superior results |
The rule supports future products
A new collagen earns its place by making the product more coherent and better supported—not by making the Roman-numeral list longer.
Sources: NCCIH · different questions require different research; NCCIH · understanding a study’s design; Harris et al. (2022) · analytical comparison of undenatured type II materials; Lugo, Saiyed and Lane (2016) · randomized trial of one undenatured type II material; Han et al. (2023) · eggshell membrane composition and processing; FDA · substantiation for dietary supplement claims
How do you evaluate a five-type or multi-collagen label?
Start with the Supplement Facts panel and ingredient list rather than the type count on the front. Record the serving size, every named collagen material and every individually declared amount. If several ingredients sit inside one proprietary-blend total, the total does not disclose the amount of each component.
Next, record source and form. A label that lists bovine, fish, chicken and eggshell-derived ingredients provides more useful information than the type numbers alone, but you still need to know whether each material is native, gelatinized or hydrolyzed. Check fish, egg or other suitability information against the complete label.
Finally, open the research behind the specific claim. Match the product’s material name and form to the study material, then record who was studied, the comparison, duration and actual endpoint. A paper explaining where type X occurs in the body cannot substitute for a human trial of the multi-collagen powder in your hand.
- What is the exact name and source of every collagen ingredient?
- Is each material native, undenatured, gelatin or hydrolyzed?
- Is an amount declared for each material, or only for the combined blend?
- Does the cited study test the same material and form at a relevant amount?
- Does current product-specific testing verify the identity and contaminants it says it checks?
- Does relevant human evidence support each outcome claim for the material and amount actually used?
- Would a simpler product answer the same goal with a clearer label?
Continue learning: Use the full collagen label and cost checklist
Sources: FDA · Supplement Facts labeling guide; NIH Office of Dietary Supplements · label information and quality; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; NCCIH · understanding a study’s design; FDA · substantiation for dietary supplement claims
Worked example: what does a 9 g five-type blend disclose?
Consider an intentionally incomplete, fictional label-reading exercise. The front names types I, II, III, V and X. The panel gives a 9 g proprietary collagen blend per serving and lists bovine-hide peptides, fish-skin peptides, chicken-cartilage material and eggshell membrane. It gives no individual material amounts or complete fish-species and allergen information. This is an original teaching example, not a real product label or a model for a compliant finished panel.
Record the 9 g as the declared total for the named blend. It is not an amount for each source or each collagen type. Dividing 9 g by five to claim 1.8 g of each type is not justified: five type names are not five equally weighted ingredients, and one source can contain more than one type. A composite ingredient such as eggshell membrane also contains non-collagen proteins, so the blend total does not establish 9 g of pure collagen.
For U.S. proprietary blends, the regulation distinguishes other dietary ingredients from ingredients with established RDIs or DRVs. The blend total and descending ingredient order do not provide an exact amount for each component; ingredients with established RDIs or DRVs have their separate declaration requirements. Keep missing fields marked unknown rather than using the front label's type count to fill them in.
| Field | What the example supplies | What you can record | What remains unknown |
|---|---|---|---|
| Type list | I, II, III, V and X on the front | Five claimed parent collagen types | Evidence for the type identity and any type-specific quantity |
| Serving amount | 9 g proprietary blend per serving | The declared combined material weight | Each ingredient amount and the blend's collagen-only content |
| Source | Bovine hide, fish skin, chicken cartilage and eggshell membrane | Four named source materials | Fish species, accepted material identities and traceability |
| Form | Peptides for the bovine and fish entries | The two entries describe a processed peptide form | The chicken and eggshell preparations; native structure cannot be assumed |
| Allergens and dietary fit | Fish- and egg-derived ingredients, without complete label information | Fish and egg declarations need checking against the complete product label | The full applicable declarations, fish species and any claimed dietary certification |
| Evidence match | No exact study material or trial supplied | An evidence question to investigate | Whether any cited research matches each purchased material, amount and claim |
Turn the gap into a specific question
Ask for the complete label, fish species, exact forms and individually disclosed material amounts where available. A type count and blend total cannot answer those questions, and this fictional exercise does not rank real products or establish an outcome.
Continue learning: Read the Supplement Facts guide for more quantity examples
Sources: FDA · Supplement Facts labeling guide; eCFR · 21 CFR 101.36 dietary supplement nutrition labeling; FDA · food allergens and label declarations; Han et al. (2023) · eggshell membrane composition and processing; NCCIH · understanding a study’s design
What evidence could justify adding another collagen material?
Dayspan can change a formula when a new material earns a defined role. The useful evidence would identify the exact ingredient and form, test a relevant amount in an appropriate population, measure the outcome the product is built around and report enough methods and limitations to judge the result.
Added-value evidence is especially useful for a combination. A study of type I peptides and a separate study of native type II do not show that combining them produces both outcomes, improves either outcome or remains practical in one serving. A combination claim needs evidence that actually answers the combination question.
FDA’s substantiation guidance also requires the evidence behind a claim to fit the claim’s full meaning. Evidence is only one product gate. A candidate material also needs a supplier specification, lawful sourcing, dietary and allergen review, stability and sensory work, an analytical plan and a label that states the amount clearly. If those pieces support a better product, the versioned formula and this guide should be updated together.
- Exact material identity and processing form
- Study-matched amount and relevant participant group
- Outcome and duration aligned with the product’s stated job
- Transparent limitations, funding and comparison group
- Finished-formula compatibility, testing and clear labeling
Sources: NCCIH · different questions require different research; NCCIH · understanding a study’s design; FDA · substantiation for dietary supplement claims; NIH Office of Dietary Supplements · what quality seals mean; FDA · Supplement Facts labeling guide
What should Dayspan verify from supplier specification to finished batch?
A product name is the beginning of material identity, not the whole quality record. The supplier specification sets the agreed identity, composition and acceptance limits for a material. A certificate of analysis reports results or confirmations for a particular lot against that specification. Finished-product records then address the formula people actually receive after blending, filling, storage and distribution.
Those documents answer different questions. An amino-acid profile can support composition without identifying every peptide sequence. A molecular-weight distribution can characterize a hydrolysate without proving a health outcome. A microbiological or contaminant result addresses the analyte and method reported; it does not silently test every possible hazard. The public explanation should name the actual scope rather than expanding one result into a blanket purity claim.
Independent certification can add useful oversight when the exact product and current listing are verified. NIH and NSF both emphasize scope: a quality seal can indicate that defined manufacturing, label or contaminant checks were performed, but it does not establish clinical effectiveness or guarantee that a product is suitable for every person. The certifier’s current database and the label version should match the item in hand.
For the prelaunch Essentials material, the responsible wording remains future-facing. Dayspan can publish the checks it plans to require, while reserving batch-specific statements until the supplier, specification, test methods, finished label and release lot exist. Once selected, the public ingredient record should name the source and material and explain exactly which records are available.
| Gate | Record or question | What it supports |
|---|---|---|
| 1. Identity | Species, tissue, collagen description, processing form and a method suited to the claimed identity | A traceable answer to what the purchased material is |
| 2. Composition | Protein or collagen basis, amino-acid profile, hydroxyproline and peptide or molecular-weight information where relevant | The stated material specification without turning chemistry into efficacy |
| 3. Source and suitability | Origin, chain of custody, animal-source statement, fish or egg allergen review and dietary-positioning facts | Accurate source, allergen and preference information |
| 4. Safety and manufacturing | Risk-based microbiological, contaminant and process controls with named methods and limits | Evidence within the actual analytes, lot and facility scope checked |
| 5. Formula performance | Flavor, aroma, color, dispersibility, packaging compatibility and stability in the complete blend | A product that remains usable and within specification through its stated life |
| 6. Evidence bridge | A comparison of purchased material, amount, population, duration and endpoint with every study used in copy | Claims that do not outrun the tested intervention |
| 7. Release and public record | Lot-specific certificate, finished-product release decision, final Supplement Facts and current certification lookup where used | A reviewable bridge from formula plan to the product sold |
Specification, certificate and certification are not synonyms
The specification defines acceptance; the certificate reports a lot; an outside certification verifies checks within its defined scope. Publish each for the question it actually answers.
Sources: NIH Office of Dietary Supplements · what quality seals mean; NSF · dietary supplement certification; NSF · checking a product’s certification; FDA · food allergens and label declarations; Oztug (2024) · peptide profiles across commercial collagen hydrolysates; FDA · Supplement Facts labeling guide; FDA · substantiation for dietary supplement claims; Dayspan ingredient library · collagen material and evidence status
Direct answers to common collagen-type questions
These answers separate biological identity from product evidence. They are intentionally direct so a reader can resolve one question without reconstructing the whole article, while the linked sources and sections above preserve the detail behind each answer.
The answers describe labels and research categories, not personal medical advice. A health condition, pregnancy, medication question or known food allergy deserves an individual conversation with an appropriate clinician and a check of the final product label.
| Question | Answer |
|---|---|
| How many collagen types are there? | A widely used scientific classification describes 28. Types I, II, III, V and X are a familiar retail subset, not all human collagens. |
| Are five collagen types better than two? | The count alone cannot show superiority. Compare the exact materials, forms, amounts, quality records and human evidence for the intended outcome. |
| Which collagen type is best for skin? | Type I is prominent in skin, and type III also occurs there, but an oral product should be judged by studies of its exact peptide material and measured skin endpoint—not tissue location alone. |
| Which collagen type is best for joints? | Type II is central to cartilage biology, but native or undenatured type II and hydrolyzed collagen are different interventions. Read the complete form name, amount and matched study. |
| Does hydrolyzed collagen keep its type? | The type can still describe the parent or source collagen. The finished hydrolysate is a heterogeneous peptide mixture rather than intact miniature fibers of that type. |
| Are types I and III enough? | They can form a coherent foundation for a defined hydrolyzed-peptide product. That does not mean two types meet every goal; it means another material should have a clear reason and evidence before it is added. |
| Is marine collagen automatically better than bovine collagen? | No universal ranking follows from the source word. Source affects origin, allergen status and material composition; the exact specification, dose and human evidence determine the comparison. |
| Does leaving out types V and X make a formula incomplete? | No. Both have real biological roles, but neither is a required checklist item for every oral formula. Their inclusion would need a material-specific purpose and evidence. |
| Does a label disclose how much of each collagen type is present? | Not necessarily. A type list may describe one source or blend without separately quantifying each type. Check the Supplement Facts, ingredient list and material specification. |
| What does a proprietary collagen blend disclose? | For “other dietary ingredients” inside a U.S. proprietary blend, the panel gives the total blend weight and lists components in descending order by weight; it generally need not give each component’s amount. Dietary ingredients with established RDIs or DRVs are listed separately with individual amounts. |
| What does “Daily Value not established” mean for collagen? | It means FDA has not established a Daily Value for that dietary ingredient. It is not a score for effectiveness, quality or the strength of the product’s research. |
| Why does Dayspan currently use I and III instead of all five? | The approved specification keeps a visible 10 g hydrolyzed bovine-hide foundation and one material-qualification process. Types II, V and X have not earned separate roles in this formula merely by increasing the type count; qualification of the exact purchased I-and-III material remains pending. |
Sources: Ricard-Blum (2011) · the collagen family; Martínez-Puig et al. (2023) · collagen source, composition and processing forms; MedlinePlus Genetics · how type I collagen is assembled; MedlinePlus Genetics · type II collagen; MedlinePlus Genetics · type V collagen and fibril assembly; NCBI Gene · type X collagen; FDA · Supplement Facts labeling guide; eCFR · 21 CFR 101.36 dietary supplement nutrition labeling; FDA · food allergens and label declarations; Dayspan Collagen Essentials · current ingredient specification; Dayspan ingredient library · collagen material and evidence status
The practical answer: choose a coherent formula, not the largest numeral list
Collagen types are useful vocabulary. They help describe the proteins in source tissues and can make a material specification more precise. They become misleading when a type count is treated as an outcome score or when tissue biology is presented as proof that an oral powder targets that tissue.
For Collagen Essentials, the current decision is a clearly stated 10 g hydrolyzed bovine-hide types I and III foundation within a combined formula. Types II, V and X are not separate actives because no product-specific reason has yet earned their inclusion. Qualification of the exact purchased peptide material and the final label remain open, and Dayspan will publish those records before sale.
Use the same method on any product: identify the goal, source, type, form, amount and exact evidence. That gives every collagen material a fair evaluation and gives future formulas room to differ for a real reason rather than collecting more numbers.
Continue learning: Learn what hydrolyzed collagen peptides are; See the complete Collagen Essentials formula
Sources: Ricard-Blum (2011) · the collagen family; Dayspan Collagen Essentials · current ingredient specification; Dayspan ingredient library · collagen material and evidence status
Sources and further reading
- Ricard-Blum (2011) · the collagen family
- MedlinePlus Genetics · how type I collagen is assembled
- MedlinePlus Genetics · type II collagen
- MedlinePlus Genetics · type III collagen
- MedlinePlus Genetics · type V collagen and fibril assembly
- NCBI Gene · type X collagen
- Martínez-Puig et al. (2023) · collagen source, composition and processing forms
- Oztug (2024) · peptide profiles across commercial collagen hydrolysates
- Harris et al. (2022) · analytical comparison of undenatured type II materials
- Correction (2022) · disclosures and amendments for the undenatured type II comparison
- Velasco-Alvarez (2022) · methodological rejoinder to the undenatured type II comparison
- Virgilio et al. (2024) · human absorption across collagen sources and molecular weights
- Kim et al. (2018) · randomized trial of one low-molecular-weight collagen hydrolysate
- Lugo, Saiyed and Lane (2016) · randomized trial of one undenatured type II material
- GELITA · collagen peptide manufacturing and properties
- Gelatine Manufacturers of Europe · gelatin and peptides
- NIDDK · your digestive system and how it works
- Iwai et al. (2005) · identifying food-derived peptides in blood
- FDA · Supplement Facts labeling guide
- eCFR · 21 CFR 101.36 dietary supplement nutrition labeling
- NIH Office of Dietary Supplements · label information and quality
- NIH Office of Dietary Supplements · what quality seals mean
- NSF · dietary supplement certification
- NSF · checking a product’s certification
- FDA · food allergens and label declarations
- Han et al. (2023) · eggshell membrane composition and processing
- NCCIH · understanding a study’s design
- NCCIH · different questions require different research
- FDA · substantiation for dietary supplement claims
- Dayspan Collagen Essentials · current ingredient specification
- Dayspan ingredient library · collagen material and evidence status
- NHGRI · what a protein is
Reference this guide
Dayspan. Collagen types I, II, III, V and X explained. Content checked October 8, 2026. https://www.dayspanhealth.com/learn/guides/collagen-types-explained.
When referencing a research finding, cite the original study linked above as well.